India to Netherlands: Topotecan Export Trade Route
India has recorded 74 verified shipments of Topotecan exported to Netherlands, representing a combined trade value of $589.3K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $8.0K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 87% of total export value with 58 shipments worth $510.8K USD. On the buying side, ALLOGA FRANCE is the largest importer in Netherlands with $129.2K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Netherlands Topotecan corridor is one of India's established pharmaceutical export routes, with 74 shipments documented worth a combined $589.3K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 87% of all export value, reflecting the consolidated nature of India's topotecan manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $8.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 32.4%, placing it at rank #9 among India's top topotecan export destinations globally.
On the import side, key buyers of Indian topotecan in Netherlands include ALLOGA FRANCE, BROCACEF NL:EU HUB, BROCACEF NL : HUB and 17 others. ALLOGA FRANCE is the single largest importer with 6 shipments valued at $129.2K USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portMUNDRA SEA (INMUN1)
Market Position
- Global rank#9
- Annual growth+32.4%
- Demand growth+27.0%
- Regulatory ease70/100
Top 10 Indian Topotecan Exporters to Netherlands
Showing top 10 of 2 Indian suppliers exporting Topotecan to Netherlands, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $8.8K per shipment | 58 | $510.8K | 86.7% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $4.9K per shipment | 16 | $78.5K | 13.3% |
This table shows the top 10 of 2 Indian companies exporting topotecan to Netherlands, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED . INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 58 shipments worth $510.8K USD, giving it a 87% market share.
Top 10 Topotecan Importers in Netherlands
Showing top 10 of 20 known buyers in Netherlands receiving Topotecan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian topotecan in Netherlands include ALLOGA FRANCE, BROCACEF NL:EU HUB, BROCACEF NL : HUB, Brocacef NL : HUB, ALLOGA France , among 20 total buyers. The largest importer is ALLOGA FRANCE, accounting for $129.2K USD across 6 shipments — representing 22% of all topotecan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ALLOGA FRANCE | 6 | $129.2K | 21.9% |
| 2 | BROCACEF NL:EU HUB | 8 | $70.0K | 11.9% |
| 3 | BROCACEF NL : HUB | 5 | $44.4K | 7.5% |
| 4 | Brocacef NL : HUB | 5 | $43.2K | 7.3% |
| 5 | ALLOGA France | 6 | $42.8K | 7.3% |
| 6 | BROCACEF NL HUB BROCACEF HEALTHCAR | 3 | $38.9K | 6.6% |
| 7 | TO THE ORDER | 9 | $33.2K | 5.6% |
| 8 | ALLOGA France | 2 | $29.4K | 5.0% |
| 9 | Brocacef NL HUB | 5 | $29.1K | 4.9% |
| 10 | BROCACEF HEALTHCARE LOGISTICS BASIC | 4 | $26.9K | 4.6% |
Showing top 10 of 20 Topotecan importers in Netherlands on this route.
Top 10 Topotecan Formulations Imported by Netherlands
Showing top 10 of 45 product formulations shipped on the India to Netherlands Topotecan route, ranked by trade value
Netherlands imports a wide range of topotecan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS MEDI TOPOTECAN INJ1MG ML 4ML RTU ACCOR FRANCE AS PER INVOICE — accounts for $81.6K USD across 3 shipments. There are 45 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS MEDI TOPOTECAN INJ1MG ML 4ML RTU ACCOR FRANCE AS PER INVOICE | 3 | $81.6K | 13.9% |
| 2 | PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML, | 10 | $74.3K | 12.6% |
| 3 | PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,4ML RTU(ACCOR-FRANCE AS PER INVOICE | 4 | $52.7K | 8.9% |
| 4 | PHARMA DRUGS & MEDI TOPOTECAN INJ RTU,1MG/ML 4ML (ACO-GER AS PER INVOICE | 3 | $46.0K | 7.8% |
| 5 | PHARMACEUTICAL DRUGS AND MEDICINE - TOPOTECAN INJ1MG/ML,1ML RTU(ACCO-BELGIUM - AS PER INVOICE | 2 | $23.6K | 4.0% |
| 6 | PHARMA DRUGS & MEDI TOPOTECAN INJ RTU,1M | 3 | $18.8K | 3.2% |
| 7 | PHARMA DRUGS & MEDI TOPOTECAN INJ RTU1MG/ML 4ML ACO-GER AS PER DOCUMENT | 1 | $18.7K | 3.2% |
| 8 | PHARMA DRUGS & MEDI TOPOTECAN INJ1MG/ML,4ML RTU(ACCO-ESTONIA AS PER INVOICE | 2 | $18.5K | 3.1% |
| 9 | PHARMA DRUGS & MEDI TOPOTECAN INJECTION1 MG/ML 4ML AS PER INVOICE | 1 | $18.1K | 3.1% |
| 10 | PHARMA DRUGS & MEDI TOPOTECAN INJECTION 1 MG/ML 4ML AS PER DOCUMENT | 1 | $18.0K | 3.1% |
Showing top 10 of 45 Topotecan formulations imported by Netherlands on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 69% sea for bulk, 18% air for urgent orders.
Top Ports of Origin
MUNDRA SEA (INMUN1) handles the highest volume with 34 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's topotecan exports to Netherlands are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 58 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Netherlands benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $8.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pharma drugs & medi topotecan inj1mg/ml, and pharma drugs & medi topotecan inj1mg/ml,4ml rtu(accor-france as per invoice, suggesting that buyers in Netherlands tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ALLOGA FRANCE is the largest importer with 6 shipments worth $129.2K USD — representing 22% of all topotecan imports from India on this route. A total of 20 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $589.3K
- Avg. Shipment
- $8.0K
- Suppliers
- 2
- Buyers
- 20
- Transit (Sea)
- ~33 days
- Annual Growth
- +32.4%
Other Topotecan Routes
Unlock the Full India to Netherlands Topotecan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 74 shipments on this route.
Frequently Asked Questions — India to Netherlands Topotecan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Topotecan to Netherlands?
The leading Indian exporters of Topotecan to Netherlands are INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED . INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 87% of total trade value on this route.
Q What is the total value of Topotecan exports from India to Netherlands?
India exports Topotecan to Netherlands worth approximately $589.3K USD across 74 recorded shipments. The average value per shipment is $8.0K USD.
Q Which ports does India use to ship Topotecan to Netherlands?
The most active port of origin is MUNDRA SEA (INMUN1) with 34 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 69% of shipments going by sea and 18% by air.
Q How long does shipping take from India to Netherlands for Topotecan?
The average transit time for Topotecan shipments from India to Netherlands is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Netherlands Topotecan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 32.4% with demand growth tracking at 27.0%. The route is ranked #9 among India's top Topotecan export destinations globally.
Q How many suppliers are active on the India to Netherlands Topotecan route?
There are currently 2 active Indian suppliers exporting Topotecan to Netherlands. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 87% of total shipment value.
Q Who are the main importers of Topotecan from India in Netherlands?
The leading importers of Indian Topotecan in Netherlands include ALLOGA FRANCE, BROCACEF NL:EU HUB, BROCACEF NL : HUB, Brocacef NL : HUB, ALLOGA France . ALLOGA FRANCE is the largest buyer with 6 shipments worth $129.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Netherlands export trade corridor identified from Indian Customs (DGFT) records for Topotecan.
- 2.Supplier/Buyer Matching: 2 Indian exporters and 20 importers in Netherlands matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 74 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
74 Verified Shipments
2 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists